You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

esophagus carcinoma

Showing 1 - 25 of 8,753
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophagus Squamous Cell Carcinoma Trial in Beijing (Palbociclib, Afatinib)

Recruiting
  • Esophagus Squamous Cell Carcinoma
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 17, 2023

EsophaCap for the Detection of Early Esophageal Carcinoma

Recruiting
  • Barrett Esophagus
  • +2 more
    • Baltimore, Maryland
    • +1 more
    Dec 8, 2022

    Colon Carcinoma, Barrett Esophagus, Gastrointestinal Dysplasia Trial (Bevacizumab-800CW)

    Not yet recruiting
    • Colon Carcinoma
    • +2 more
    • (no location specified)
    Aug 22, 2023

    Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab)

    Completed
    Has Results
    • Esophageal Carcinoma
    • Esophagogastric Junction Carcinoma
    • pembrolizumab
    • (no location specified)
    Aug 18, 2022

    Esophagus Cancer, Esophageal Cancer, Esophageal Tumors Trial in Pittsburgh (ActivSight)

    Not yet recruiting
    • Esophagus Cancer
    • +9 more
    • ActivSight
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center - Dept of Cardiothoracic
    Jan 31, 2023

    Esophagus Cancer, Carcinoma Esophagus Trial (Supercharged TRAM esophagectomy, Conventional Esophagectomy)

    Not yet recruiting
    • Esophagus Cancer
    • Carcinoma Esophagus
    • Supercharged TRAM esophagectomy
    • Conventional Esophagectomy
    • (no location specified)
    Jul 13, 2023

    ctDNA-MRD in Predicting Efficacy of Esophageal Squamous Cell

    Not yet recruiting
    • Squamous Cell Carcinoma of Esophagus
      • (no location specified)
      Feb 25, 2023

      Locally Advanced Esophageal Carcinoma Trial in Nanjing (Neoadjuvant Chemotherapy, Neoadjuvant Toripalimab, Short Course

      Recruiting
      • Locally Advanced Esophageal Carcinoma
      • Neoadjuvant Chemotherapy
      • +2 more
      • Nanjing, Jiangsu, China
        Jiangsu Cancer Hospital /Jiangsu Institute of Cancer Research
      Jun 21, 2022

      Barrett's Esophagus Trial in United States (Sponge capsule)

      Completed
      Has Results
      • Barrett Esophagus
      • Biopsy
      • +3 more
      • Scottsdale, Arizona
      • +5 more
      Nov 14, 2022

      Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)

      Not yet recruiting
      • Esophagus Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University
      Nov 20, 2023

      Esophagus Cancer Trial in Tianjin (Camrelizumab, Paclitaxel, Cisplatin)

      Recruiting
      • Esophagus Cancer
      • Tianjin, Tianjin, China
        Affiliated Cancer Hospital of Tianjin Medical University
      Nov 24, 2022

      Immunotherapy Esophagus Cancer Trial (Tislelizumab, Albumin paclitaxel, Nedaplatin)

      Not yet recruiting
      • Immunotherapy Esophagus Cancer
      • (no location specified)
      Aug 24, 2022

      Esophagus Cancer Trial in Xiamen (Tislelizumab, Paclitaxel-albumin, Carboplatin)

      Recruiting
      • Esophagus Cancer
      • Xiamen, Fujian, China
        ShanghaiZhongshan
      Apr 8, 2023

      Neoadjuvant Chemotherapy Compared With Surgery for Esophageal

      Completed
      • Esophagus Cancer
      • Paclitaxel- and platinum-based chemotherapy
      • Zhengzhou, Henan, China
        Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
      Oct 5, 2022

      Primary Tumor Burden Score:A Novel Staging Parameter for ESCC

      Completed
      • Neoplasm, Esophagus
      • Neoplasm, Squamous Cell
      • nCRT
      • (no location specified)
      Apr 20, 2023

      Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab, paclitaxel, docetaxel)

      Completed
      Has Results
      • Esophageal Carcinoma
      • Esophagogastric Junction Carcinoma
      • pembrolizumab
      • +3 more
      • (no location specified)
      May 5, 2022

      Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)

      Not yet recruiting
      • Cancer Risk
      • +30 more
      • Samples
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jul 14, 2022

      Non-small Cell Lung Carcinoma, Small Cell Lung Carcinoma Trial in Boston, Newton (Contralateral Esophageal Sparing Technique

      Completed
      Has Results
      • Non-small Cell Lung Carcinoma
      • Small Cell Lung Carcinoma
      • Contralateral Esophageal Sparing Technique (CEST)
      • Boston, Massachusetts
      • +1 more
      Dec 8, 2021

      Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

      Recruiting
      • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
      • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
      • Guangzhou, Guangdong, China
        Cancer center of Sun Yat-sen University
      Jul 20, 2022

      Stage IV Esophagus Squamous Cell Carcinoma Trial in Hangzhou (Camrelizumab, Irinotecan, Paclitaxel)

      Not yet recruiting
      • Stage IV Esophagus Squamous Cell Carcinoma
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Apr 2, 2022

      Esophageal Cancer, Squamous Cell Esophagus Cancer, Adenocarcinoma Esophagus Trial in Boston (Pembrolizumab)

      Active, not recruiting
      Has Results
      • Esophageal Cancer
      • +2 more
      • Boston, Massachusetts
      • +2 more
      Apr 7, 2022

      Sequence and Time-of-day Infusion of immunoCHemotherapy Affect

      Completed
      • Esophagus Cancer
        • Guangzhou, Guangdong, China
          Guangdong Provincial People's Hospital
        Nov 24, 2022

        Esophagus SCC Trial in Jinan (Sintilimab Injection plus Paclitaxel and Cisplatin, Paclitaxel and Cisplatin)

        Withdrawn
        • Esophagus SCC
        • Sintilimab Injection plus Paclitaxel and Cisplatin
        • Paclitaxel and Cisplatin
        • Jinan, Shandong, China
          Qilu Hospital of Shandong University
        Apr 19, 2022

        Carcinoma, Esophagus Cancer Trial in Chengdu (Tumor antigen-sensitized DC vaccine)

        Not yet recruiting
        • Carcinoma
        • Esophagus Cancer
        • Tumor antigen-sensitized DC vaccine
        • Chengdu, Sichuan, China
          West China Hospital
        Aug 21, 2021

        Esophagus Cancer Trial in United States (Oxaliplatin, Docetaxel, Capecitabine)

        Completed
        Has Results
        • Esophagus Cancer
        • Beverly Hills, California
        • +6 more
        Oct 29, 2021